A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome
- 1 August 2000
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 106 (3), 393-402
- https://doi.org/10.1172/jci7771
Abstract
Euthyroid sick syndrome, characterized by low serum 3,5,3′-triiodothyronine (T3) with normal L-thyroxine levels, is associated with a wide variety of disorders including sepsis, malignancy, and AIDS. The degree of low T3 in circulation has been shown to correlate with the severity of the underlying disorders and with the prognosis. Elevated TNF-α levels, which accompany severe illness, are associated with decreased activity of type I 5′-deiodinase (5′-DI) in liver, leading us to speculate that high levels of this factor contribute to euthyroid sick syndrome. Here we demonstrate that the activation of NF-κB by TNF-α interferes with thyroid-hormone action as demonstrated by impairment of T3-dependent induction of 5′-DI gene expression in HepG2 cells. Inhibition of NF-κB action by a dominant-negative NF-κB reversed this effect and allowed T3 induction of 5′-DI. Furthermore, we show that an inhibitor of NF-κB activation, clarithromycin (CAM), can inhibit TNF-α–induced activation of NF-κB and restore T3-dependent induction of 5′-DI mRNA and enzyme activity. These results suggest that NF-κB activation by TNF-α is involved in the pathogenesis of euthyroid sick syndrome and that CAM could help prevent a decrease in serum T3 levels and thus ameliorate euthyroid sick syndrome.This publication has 55 references indexed in Scilit:
- Intracellular Proteolytic Cleavage of 9-cis-Retinoic Acid Receptor α by Cathepsin L-type Protease Is a Potential Mechanism for Modulating Thyroid Hormone ActionPublished by Elsevier BV ,1998
- The Gene Regulating Activity of Thyroid Hormone Nuclear Receptors Is Modulated by Cell-Type Specific FactorsBiochemical and Biophysical Research Communications, 1997
- Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.Genes & Development, 1995
- Erythromycin Suppresses Interleukin 6 Expression by Human Bronchial Epithelial Cells: A Potential Mechanism of Its Anti-inflammatory ActionBiochemical and Biophysical Research Communications, 1995
- Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.JCI Insight, 1994
- Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptorCell, 1990
- Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform ExtractionAnalytical Biochemistry, 1987
- Peripheral Serum Thyroxine, Triiodothyronine and Reverse Triiodothyronine Kinetics in the Low Thyroxine State of Acute Nonthyroidal IllnessesJCI Insight, 1982
- Hypothyroxinemia in critically ill patients as a predictor of high mortalityJAMA, 1981
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979